Sirolimus 1mg/mL; contains alcohol. Sirolimus inhibits T-lymphocyte activation and proliferation that occurs in response to antigenic and cytokine (IL-2, IL-4, and IL-15) stimulation by a ...

According to the latest Enforcement Report of United States Food and Drug Administration (USFDA), Dr Reddy's US arm Dr Reddy's Laboratories Inc is recalling 9,330 bottles of Sirolimus tablets ...

Purpose: The mechanism of action and pharmacokinetics of sirolimus when used as part of a drug-eluting stent (DES) and the efficacy and cost of using DESs versus bare-metal stents are discussed.

LONDON, England—While it’s not clear sirolimus-based devices will ever overtake the old workhorse paclitaxel, data from several studies presented here at the 2025 Charing Cross International Symposium ...

Results from two retrospective studies have now added to the mounting evidence that sirolimus is associated with serious adverse events.